• WSIC receives funding in the European IMAGIO research consortium

    The European research consortium IMAGIO "Imaging and Advanced Guidance for workflow optimization in Interventional Oncology" is funded with 24 million euros by the Innovative Health Initiative (IHI). The Department of Preclinical Imaging and Radiopharmacy (Prof. Dr. Bernd Pichler) is part of this consortium.

    Read more

  • New Horizons - Symposium in honor to Prof. Dr. Mikhail Shapiro and workshop

    On 25.10.-26.10.2022, a symposium on "New Horizons in Precision Medical imaging and Therapy" will take place. Keynote speaker will be Prof. Dr. Mikhail Shapiro, Caltec, USA. On 27.10.2022, a demonstration workshop on "Gene-encoded Gas Vesicles for Molecular Focused Ultrasound Imaging in Cells" will follow.

    For information and registration click here

     

    Read more

  • WSIC receives 18.4 million euros in funding from the Werner Siemens Foundation

    The Werner Siemens Imaging Center (WSIC) at the Radiological University Hospital Tübingen and the Medical Faculty of the University of Tübingen is pleased to announce that it has received a total of 18.4 million euros in funding from the Swiss Werner Siemens Foundation (WSS)

    Read more

  • Annette Widmann-Mauz visits the Werner Siemens Imaging Center

    Mrs. Annette Widmann-Mauz (MdB), Minister of State and Tübingen CDU constituency representative, visited the WSIC for a roundtable discussion on the topic of the planned regional light rail system.For the largest infrastructure project in the Neckar-Alb region, the WSIC would have to change its current location.

     

    Read more

  • Innovative method to improve cancer immunotherapy

    The Preclinical Imaging and Radiopharmacy Department of the University Hospital Tübingen and ImaginAb, a global market leading biotech company, are cooperating in the field of cancer immunotherapy making Tübingen Europe's first center for the production of radiolabeled CD8 minibodies.

    Read more

  • TheranosticValleySTR project outline reaches 2nd round of BMBF "Clusters4Future" call

    TheranosticValleySTR (STR= Research and Economic Region Stuttgart, Tübingen, Reutlingen) represents the concept for an innovative future cluster to fundamentally improve diagnosis and therapy of cancer, infectious and neurological diseases. The main drivers of this concept, the University of Tübingen, MPI Tübingen-Stuttgart and the NMI Reutlingen, are among the 15 chosen conceputal clusters (out of 117 applicants) to hand in a full concept. 

     

    Read more

  • Biologicals Development Center becomes new RegioWIN lighthouse project

    Ministers of the state of Baden-Württemberg announced the funding of the Biologicals Development Centre with the NMI in Reutlingen and the Werner Siemens Imaging Centre (WSIC) of the University and University Hospital of Tübingen as the responsible project promoters at the award ceremony for RegioWIN projects. The goal of the partners is to design, produce, functionalise and test biotechnologically produced proteins, so-called biologicals, in cooperation with academic groups and companies and to quickly bring them into use.

     

    Read more

  • New diagnostic procedure for pulmonary aspergillosis

    For people with a weakened immune system, invasive pulmonary aspergillosis, a fungal infection of the lungs, poses a great danger. In search of a new diagnostic method, the University Hospital of Tübingen has therefore joined forces with its scientific partners to investigate a new antibody-guided imaging method. The study is currently published in the renowned journal Nature Communications.

    Read more

  • New National Center for Tumor Diseases (NCT) site in Tübingen

    With the National Decade against Cancer, the Federal Ministry of Education and Research (BMBF) is strengthening cancer research by expanding the two existing sites of the National Center for Tumor Diseases (NCT) by four additional locations - one of those located in Tübingen.

    Read more

  • Radiology researcher receives Humboldt Foundation Sofja Kovalevskaja Award

    Dr. André Martins is one of this year's recipients of the Alexander von Humboldt Foundation's Sofja Kovalevskaja Award. This award, one of the highest endowed science awards in Germany, honors talented early-career international researchers.

    Read more

  • Professor Bernd Pichler elected as new Dean of the Medical Faculty

    Professor Bernd Pichler is the new Dean of the Medical Faculty at the University of Tübingen.

    Read more

  • EU funding to improve immunotherapies

    The Tübingen Radiopharmacy develops new immune cell tracers:

    The University Hospital of Tübingen is participating in a Europe-wide research project on immune imaging.

     

    Read more

  • Successful application for Cluster of Excellence (iFIT)

    The Image-Guided and Functionally Instructed Tumor Therapies (iFIT) Cluster of Excellence succeeded in the application for a seven years funding period.

    Read more

  • K.H. Eberle-Innovation Award for Tübingen Research Project

    The K.H. Eberle Foundation award was granted for the first time at the University Tübingen – The award goes to natural scientists and physicians developing alternative methods in animal research

    Read more

  • Professor Bernd Pichler new member of the Leopoldina

    Professor Bernd Pichler, radiologist at the University Hospital of Tübingen and head of the Werner Siemens Imaging Center (WSCI), was elected a member of the Leopoldina in July. The membership is an award for his scientific achievements.

    Read more

  • 2nd edition of "Small Animal Imaging" published

    This textbook is a practical guide to the use of small animal imaging in preclinical research that will assist in the choice of imaging modality and contrast agent and in study design, experimental setup, and data evaluation.

    Read more

  • OpenMS featured in the Sustainable Software Institute's blog

    The article is part of the SSI series 'A day in the software life,' in which researchers from all disciplines discuss the tools that make their research possible.

    Read more

  • Prof. Bernd Pichler admitted to the National Academy of Science and Technology